The Global Helicobacter Pylori Diagnostic Market Size is valued at 559.89 million in 2023 and is predicted to reach 911.50 million by the year 2031 at a 6.31% CAGR during the forecast period for 2024-2031.
Helicobacter pylori (H. pylori), an aerobic, gram-negative bacterium, is frequently found in the stomach. It is vital to the preservation of the stomach environment. The spiral-shaped bacteria that cause H. infection with pylori penetrate the esophagus, small intestine, and stomach lining, increasing the risk of gastric cancer, peptic ulcers, and chronic gastritis.
One of the most significant factors that will contribute to the growth of the helicobacter pylori diagnostic market is the rising number of patients with gastric ulcers. Other important factors include the rising prevalence of geriatrics worldwide, the rising demand for point-of-care testing devices, the growing adoption of non-invasive testing, and the simple accessibility of diagnostic tests.
On the other hand, growing technological development, increased innovations, and increased product approvals will all contribute to expanding the helicobacter pylori diagnostic market during the period covered by the projections above. In emerging nations, there are expected to be market restrictions on developing the helicobacter pylori diagnostic market due to a lack of experienced specialists and knowledge about the advantages of testing.
The Helicobacter pylori diagnostic market is segmented by technology and end user. The technology segment includes Immunoassays, POC, and Molecular Diagnostics. By the end user, the market is segmented into Hospitals, Diagnostics Laboratories, and Clinics.
The immunoassay segment had the most significant market share and is expected to continue to dominate the market over the coming years. For the detection of antibodies, a number of cutting-edge technologies are used, such as enzyme immunoassays. Serology, fast urease tests, and urea breath tests are a few of the indirect tests. Although molecular diagnostics represented the second-largest market share, POC tests still accounted for some of the most frequently employed methods.
Due to the simplicity of disease presentation, the accessibility of doctors, and the increased occurrence of diseases such as duodenal ulcers, stomach cancer, gastritis, gastric ulcers, and infections of the small intestine, hospitals held the most significant market share.
Throughout the projection period, North America is expected to dominate the global market for helicobacter pylori diagnostics. Infectious disease instances, awareness of contagious diseases, and introduction of new products are all contributing causes to the growth. For instance, Biomerica Inc. announced in June 2021 that it had inked a five-year exclusive distribution agreement with a Canadian partner to distribute and market Biomerica's innovative and exclusive Helicobacter pylori test, known as hp+detect. Helicobacter pylori infection, the most common cause of duodenal and gastric ulcers and a risk factor for stomach cancer, have been targeted by developing the hp+detect product. Therefore, such occurrences are projected to fuel market growth in the North American area.
| Report Attribute | Specifications |
| Market size value in 2023 | USD 559.89 Mn |
| Revenue forecast in 2031 | USD 911.50 Mn |
| Growth rate CAGR | CAGR of 6.31% from 2024 to 2031 |
| Quantitative units | Representation of revenue in US$ Billion, and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
| Segments covered | Technology And End User |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | Thermo Fisher Scientific, Biohit, Quest Diagnostics, Meridian Bioscience, Bio-Rad Laboratories, Alpha Laboratories, F. Hoffmann-La Roche, Coris BioConcept, Certest Biotec, and Epitope Diagnostics. |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Helicobacter Pylori Diagnostic Market By Technology-
Helicobacter Pylori Diagnostic Market By End-User-
Helicobacter Pylori Diagnostic Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.